Generate Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.87M Buy
+25,518
New +$9.46M 0.41% 64
2026
Q1
Sell
-17,500
Closed -$6.13M 75
2025
Q4
$6.13M Sell
17,500
-117,500
-87% -$39.7M 0.28% 67
2025
Q3
$43.6M Buy
135,000
+36,948
+38% +$11.5M 2.21% 10
2025
Q2
$38.1M Buy
98,052
+60,963
+164% +$24.5M 2.12% 13
2025
Q1
$16.1M Sell
37,089
-36,848
-50% -$14.8M 1.13% 28
2024
Q4
$27.3M Buy
73,937
+20,725
+39% +$8.67M 1.91% 14
2024
Q3
$27.7M Sell
53,212
-6,035
-10% -$3.22M 1.85% 19
2024
Q2
$32.1M Buy
+59,247
New +$31.3M 1.89% 13

Other funds holding ELV

Generate Investment Management's ELV Position: Q2 2026 in Review

Generate Investment Management opened a new position in Elevance Health (ELV) in Q2 2026: 25,518 shares worth $9.87M. The stake represents 0.41% of the portfolio and ranks #64 among its holdings. This is a return to the name: Generate Investment Management previously reported a position in ELV as recently as Q4 2025.

Generate Investment Management first reported a position in ELV in Q2 2024 and has held it in 8 quarters since. The position peaked at $43.6M in Q3 2025. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Generate Investment Management held 25,518 shares of Elevance Health worth $9.87M as of Q2 2026.
  • Elevance Health was a new Generate Investment Management position in Q2 2026.
  • Elevance Health made up 0.41% of Generate Investment Management's portfolio in Q2 2026, its #64 holding.
  • Generate Investment Management first reported a position in Elevance Health in Q2 2024 and has held it in 8 quarters since.
  • Generate Investment Management's Elevance Health position peaked at $43.6M in Q3 2025.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Generate Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.